Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy
Canadian Medical Association Journal2008Vol. 179(5), pp. 417–426
Citations Over TimeTop 1% of 2008 papers
Marc Rodger, Susan R. Kahn, Philip S. Wells, David R. Anderson, Isabelle Chagnon, Grégoire Le Gal, Susan Solymoss, Mark Crowther, Arnaud Perrier, R. White, L. Vickars, Tim Ramsay, Marisol T. Betancourt, M.J. Kovacs
Abstract
Women with 0 or 1 risk factor may safely discontinue oral anticoagulant therapy after 6 months of therapy following a first unprovoked venous thromboembolism. This criterion does not apply to men.